Security key
14147L108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 433,337
- Total 13F value
- $561,350
- Share change
- -15,027
- SEC-reported price per share
- $1.30
- Number of holders
- 23
- Value change
- -$42,184
- Number of buys
- 11
- Number of sells
- 7
- Shares outstanding
- 66,404,538
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
23
Top holders
10
CRDF full security history
Ownership snapshot
Full 13F holder table
Cardiff Oncology, Inc. SEC filings
Cardiff Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 14147L108
Recent filing periods:
Ownership snapshot
Top reported holders of CRDF - Cardiff Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PFIZER INC
Disclosed value leader
PFIZER INC
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 3.6%
13D/G row: PFIZER INC
Showing 1-6 of 15 holder rows.
Quick read
PFIZER INC leads the comparable SEC ownership view at 3.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PFIZER INC's linked filing trail.
Comparable ownership
Top 5
PFIZER INC
3.6%
BlackRock, Inc.
1.3%
VANGUARD CAPITAL MANAGEMENT LLC
4.3%
Laurion Capital Management LP
4%
ACORN CAPITAL ADVISORS, LLC
2.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PFIZER INC |
13D/G
13F
Pfizer Inc. 13-5315170 · Company
|
3.6%
|
$6,704,178
2,411,575 shares
|
$0 | 31 Dec 2024 |
| BlackRock, Inc. |
13F
13D/G
Company
|
1.3%
from 13D/G
|
$6,449,847
3,981,387 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
4.3%
|
$4,626,665
2,855,966 shares
|
— | 31 Mar 2026 |
| Laurion Capital Management LP |
13F
Company
|
4%
|
$4,287,716
2,646,738 shares
|
— | 31 Mar 2026 |
| ACORN CAPITAL ADVISORS, LLC |
13F
Company
|
2.7%
|
$2,854,576
1,762,084 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.4%
|
$2,592,106
1,599,663 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
433,337
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
115
Q2 2026 holders
23
Holder diff
-92
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend